Belize vs Suriname: Cause of death, by non-communicable diseases, ages 15-59
Belize
42.8%
in 2021
Suriname
43.1%
in 2021
Belize rank
141st
Suriname rank
139th
Cause of death, by non-communicable diseases, ages 15-59 over time
- Belize
- Suriname
How they compare
Suriname currently reports 43.1% against 42.8% in Belize, a difference of 0.3%.
Across all 6 years both countries report, Suriname has been ahead every year.
Belize ranks 141st and Suriname ranks 139th of 185 countries.
Suriname has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belize | Suriname | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44.0% | 45.7% | 1.7% | Suriname |
| 2010s | 45.1% | 58.5% | 13.4% | Suriname |
| 2020s | 44.5% | 51.7% | 7.2% | Suriname |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Belize or Suriname?
- Suriname, at 43.1% against 42.8% in Belize as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Belize and Suriname?
- 0.3%, with Suriname ahead.
- How many years of comparable data are there for Belize and Suriname?
- 6 years are reported by both, from 2000 to 2021.
- How do Belize and Suriname rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Belize ranks 141st and Suriname ranks 139th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.